Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype

25 Mar 2019

Abstract excerpt

BACKGROUND: Tiotropium add-on therapy has demonstrated efficacy and safety in 6- to 17-year-olds with symptomatic asthma despite treatment with inhaled corticosteroids (ICSs), with or without additional controllers. Pediatric patients often have a significant allergic component to their asthma. OBJECTIVE: To explore whether responses to tiotropium add-on were influenced by patients' type 2 status, assessed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allergic Rhinitis and Sensitization
Share to Asthma and respiratory diseases
Share to Indoor Air Quality and Microbial Exposure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30922990
DOI: 10.1016/j.jaip.2019.03.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 PhenotypePMID 30922990Read ↗

Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.Semantic proximity Read ↗

Baseline Type 2 Biomarker Levels and Clinical Remission Predictors in Children with AsthmaSemantic proximity Read ↗

Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotypeSemantic proximity Read ↗

Tiotropium Bromide in Children and Adolescents with Asthma.Semantic proximity Read ↗

Optimizing maintenance therapy in pediatric asthma.Semantic proximity Read ↗

Impact of Age and Sex on Response to Asthma Therapy.Semantic proximity Read ↗

Efficacy and Safety of Add-On Omalizumab in 4-6-Year-Old Children with Uncontrolled Allergic Asthma: A 52-Week Retrospective StudySemantic proximity Read ↗

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype - a randomized controlled trial study protocol.Semantic proximity Read ↗

Blood eosinophils in managing preschool wheeze: lessons learnt from a proof-of-concept trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.